Equities

Emami Ltd

EMAMILTD:NSI

Emami Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (INR)724.20
  • Today's Change-14.65 / -1.98%
  • Shares traded1.09m
  • 1 Year change+71.21%
  • Beta1.0369
Data delayed at least 15 minutes, as of Jul 05 2024 11:25 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Emami Limited is an India-based fast moving consumer goods (FMCG) company, which is engaged in manufacturing and marketing of personal care and healthcare products. The Company's brands comprise Navratna, Zandu, BoroPlus, Kesh King, Fair and Handsome, Mentho Plus, 7 Oils in One and Dermicool, among others. It has over 450 diverse products. Its Navratna brand provides soothing relief and relaxation. The range includes cooling oils and talc. Its Kesh King branded products include Kesh King Ayurvedic Oil, organics range - shampoos, Kesh King Ayurvedic Shampoo, Kesh King capsule and Kesh King conditioner. Its products are available in over 4.9 million retail outlets across India through its network of 4000 distributors and its global footprint spans over 70 countries including South Asian Association for Regional Cooperation (SAARC), Middle East and North Africa and South Asia (MENAP), Southeast Asian (SEA), Africa, Eastern Europe and the Commonwealth of Independent States (CIS) countries.

  • Revenue in INR (TTM)35.78bn
  • Net income in INR7.24bn
  • Incorporated1983
  • Employees3.24k
  • Location
    Emami LtdEmami Tower, 687 Anandapur,, EM BypassKOLKATA 700107IndiaIND
  • Phone+91 3 366136264
  • Fax+91 3 366136600
  • Websitehttp://www.emamiltd.in/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
EMAMILTD:NSI since
announced
Transaction
value
Brillare Science Pvt LtdDeal completed27 Mar 202427 Mar 2024Deal completed66.48%--
Data delayed at least 15 minutes, as of Jul 05 2024 11:25 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Jyothy Labs Ltd27.57bn3.69bn173.12bn2.94k46.819.5741.296.2810.0710.0775.1449.241.244.8016.269,367,754.0016.5511.1620.6814.5949.0843.6013.4010.141.7890.880.027251.5010.908.7454.1112.49-1.473.13
Gillette India Limited26.07bn3.87bn234.73bn571.0060.58--49.889.00118.91118.91800.11--------45,660,070.00--20.15--31.7553.7452.2914.8613.99--56.36--75.439.798.1222.939.20-0.581629.88
Emami Ltd35.78bn7.24bn316.11bn3.24k43.7613.0034.748.8316.5516.5581.8055.721.123.567.87--22.6720.4329.6427.9167.5765.7920.2418.751.4455.740.0368--5.065.8513.1319.00-21.8514.87
Procter & Gamble Hygiene & Health Care41.26bn7.45bn539.31bn432.0072.37--67.1013.07229.57229.571,271.24--------95,520,370.00--32.29--57.6861.3849.0218.0615.90--33.77--68.620.43539.8017.7812.603.1235.84
Colgate-Palmolive (India) Ltd56.80bn13.24bn791.61bn2.22k59.8042.2352.9413.9448.6748.67208.8568.911.875.4534.9825,575,950.0043.5437.3570.4963.1569.6760.8223.3020.891.30346.810.0369108.268.694.9526.4111.28-11.4515.85
Dabur India Ltd124.04bn18.43bn1.07tn5.32k58.4210.8948.628.6710.3810.3869.8755.680.86213.2514.20--12.5914.5017.8220.2548.0347.9214.6015.820.949716.050.11743.887.587.777.945.0219.200.00
Godrej Consumer Products Limited140.96bn-5.61bn1.41tn2.51k--11.15--9.97-5.48-5.48137.83123.170.78324.5010.14---3.117.68-4.1310.3955.1650.40-3.9810.030.76756.690.2037--5.866.45-132.93--8.149.95
Data as of Jul 05 2024. Currency figures normalised to Emami Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

19.90%Per cent of shares held by top holders
HolderShares% Held
DSP Asset Managers Pvt. Ltd.as of 31 May 202416.10m3.67%
HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 31 May 202413.19m3.01%
Kotak Mahindra Asset Management Co. Ltd.as of 31 May 202410.97m2.50%
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 May 202410.40m2.37%
The Vanguard Group, Inc.as of 06 Jun 20247.81m1.78%
SBI Funds Management Ltd.as of 30 Jun 20247.18m1.64%
UTI Asset Management Co. Ltd. (Investment Management)as of 30 Jun 20245.80m1.32%
Invesco Advisers, Inc.as of 31 May 20245.58m1.27%
PineBridge Investments Asia Ltd.as of 31 Dec 20235.19m1.18%
Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 31 May 20245.13m1.17%
More ▼
Data from 31 Mar 2024 - 04 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.